John Guarino Recognized as a PharmaVOICE 100 Leader

Palio+Ignite, part of inVentiv Health Communications, announces that John Guarino, EVP, Managed Markets & Payer Strategy, has been named by PharmaVOICE as one of the 100 most inspiring leaders in the healthcare industry.


The PharmaVOICE 100 is an annual list of people recognized for their significant contributions to the life-sciences industry. Inclusion in PharmaVOICE 100 is an acknowledgement of Guarino’s ability to provide exemplary leadership and foster innovation. 


Guarino, who has more than two decades of industry experience, is a respected leader in managed markets communications, helping clients navigate complex managed care and government reimbursement issues. His expertise spans market access, tiered formulary insurance, reimbursement, specialty drugs and specialty pharmacy, and contracting profitability. Among his innovations, Guarino launched a blog series focused on comparative effectiveness research, Medicare Part D, and the Affordable Care Act.  He excels at building relationships and creating opportunities for Palio+Ignite and its clients.


“At a moment when the public conversation is shifting from cost to value, marketers and agencies need to change their approach. John is the kind of visionary leader who anticipates change and helps clients navigate the fast-evolving managed-market landscape,” said Bob Chandler, president of inVentiv Health Communications.


This is the ninth annual PharmaVOICE 100 list.  It showcases leaders in health and medicine who view industry trends as challenges not burdens, as opportunities not obstacles. According to PharmaVOICE, they are individuals who embody passion and conviction, who are creators of out-of-the box and breakthrough strategies, products, and services – people who pioneer paths and lift their companies to new heights.  Guarino is featured in the July/August issue of the PharmaVOICE publication.


“The headline on John’s profile in the magazine is ‘Driven to Innovate’ and we think that sums up his approach to his work here,” said Mike Myers, president of Palio+Ignite. “John has been quick to identify and deliver on an emerging need and we all congratulate him on this well-deserved industry recognition.”


inVentiv Health Communications, a division of inVentiv Health, is dedicated to delivering exceptional global, multichannel communications to organizations focused on health and wellness.  Palio+Ignite is an advertising agency within the communications division focused on revolutionizing healthcare marketing by leveraging the art and science of today with the technology and imagination of tomorrow. For more information, visit


Saratoga Springs, NY, April 26, 2013 – Palio+Ignite, an inVentiv Health company, is pleased to announce that their Bydureon Team received the 2013 Brand Team of the Year Award. This distinguished award was presented by Med Ad News, a business newsmagazine for the pharmaceutical business and marketing community.

Each year, Med Ad News recognizes excellence among the top advertising agencies in the United States, in areas ranging from most creative to best professional Web site. Winners of the 2013 competition were announced at the 24th Annual Manny Awards on April 25.

“This award is an incredible testament to what we have accomplished and continue to accomplish across our geographies,” said Mike Myers, president of Palio+Ignite. “I need to thank the spirit and enthusiasm of our talented employees who won the award for the agency, and our clients, who continually give us the opportunity to produce great work on the brands we support. It’s the incredible people we work with every day that makes receiving such prestigious recognition so gratifying.”

The Brand Team of the Year award recognizes Palio+Ignite’s leadership, exceptional dedication, teamwork, and their ability to meet challenges, effectively communicate with clients, and implement new concepts.

This award acknowledges how our bicoastal Bydureon Team delivered the ‘music of continuous glycemic control’ campaign to transcend borders and redefine type 2 diabetes. ‘Music’ is a truly global campaign that’s run from Jersey to Japan, and graphically brings to life the new hope and control that Bydureon offers,” said Paul Johnson, EVP, Managing Director of Client Services at Palio+Ignite. “Today we’re partnering with BMS/AZ to continue to grow Bydureon, and reshape the T2D paradigm.”

Palio+Ignite is an advertising agency revolutionizing healthcare marketing by leveraging the art and science of today with the technology and imagination of tomorrow. For more information, visit


About inVentiv Health inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. In 40 countries around the world, inVentiv’s 13,000 employees help clients rapidly transform promising ideas into commercial reality.  inVentiv clients include more than 550 pharmaceutical, biotech and life sciences companies, as well as companies that now see health as part of their mission.  inVentiv Health Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit


Social Health Startup Bootcamp at SXSW 2013

Saratoga Springs, NY, March 8, 2013 ­­– App inventor and endocrinologist, Jennifer Dyer, MD, MPH, is a panelist on the Social Health Startup Bootcamp (#SXSHbooty) discussion, Show me the Money $$$: Where to Get Funding, What They’re Interested In, and Why. Dyer, inventor of EndoGoal App, joins fellow panelists from the health incubators, StartUp Health, California HealthCare Foundation Health Innovation Fund, and GE Healthymagination Fund. Panelists will be discussing alternative forms of funding for health tech start-ups. The Bootcamp discussion takes place today, March 8, from 2 to 6 PM in Salon D of the Hilton Austin, as part of the annual South by Southwest (SXSW) interactive festival in Austin, Texas.

The Social Health Startup Bootcamp focuses on opportunities for investing in health innovation, and encourages innovators, technologists, and potential tech start-up founders to consider health as a viable option for launching a company. Led by Shwen Gwee, founder and organizer of the Social Health Startup Bootcamp, and founder and producer of PharmFresh.TV and the Social Health Summit (, this year’s Bootcamp will feature key executives from event sponsor, Aetna, discussing how now is the optimal time to invest in health innovation. Bootcamp will also showcase interviews with 3 successful health tech start-ups, moderated by Jason Calacanis, serial Internet entrepreneur/investor and host of This Week in Startups, and the panel on options for alternative funding options specifically for health tech start-ups.

“There has been so much attention directed towards consumer technology startups, where competition for funding and survival is fierce. Yet, the focus on social heath startups is only just starting to take flight,” said Gwee, who is also the digital health lead at Edelman. “In the last few years, we’ve witnessed an acute growth in the awareness of how technology and health intersect, particularly around digital health technologies that are connected via mobile devices. It is important that we show the opportunities for investing in and developing connected health solutions which are becoming more mainstream in the general consumer world. And, what better place to do that than at the SXSW festival.”

“The mHealth movement is upon us,” said Dyer. “For physicians to prescribe mHealth applications to patients, and for insurance companies to consider paying patients to use the app, the app must demonstrate that it can effectively help improve health outcomes. It’s all about health-caring and health-sharing. With the clinical trials we hope to demonstrate that EndoGoal can indeed enable diabetics to lead a healthier lifestyle.”

Palio+Ignite, an inVentiv Health agency, played a critical role in helping Dyer reach her fundraising goal by providing more than 50% of the funding for the EndoGoal App clinical trial through the crowdfunding website, MedStartr. The app was originally designed as a way to reward the good behavior of patients for better managing their diabetes. “The reward feature is unique to EndoGoal,” said Dyer. “It helps reinforce good behavior, which ultimately results in positive behavioral modification.” EndoGoal allows patients to manage their diabetes through journal entries of blood glucose recordings. When using the app, patients have the ability to set reminders to take daily recordings and add notifications for appointments that sync directly to the calendar on their phone.

To ensure that she had the attention of her patients, Dyer asked for feedback on EndoGoal. Those using the app suggested a more interactive component and Dyer introduced gamification features to further engage patients while continuing to reward their good behavior. The gamification component enables patients to interact with and take care of “Cooper,” a virtual golden retriever.

Patients care for Cooper through blood glucose recordings and earn weekly rewards. Each recording is rewarded with a point, and when a patient reaches 3 out of the 4 desired readings for the day, Cooper’s dog bowl is filled with food, allowing him to be satisfied. Once a patient reaches the final reading, a bonus prize of a bone is then given to Cooper. “It’s a way of gamifying the app so that you get a reward for doing the behavior you should be doing and it makes you feel good to know that Cooper is being well taken care of. When he’s being neglected, he’ll cry and whine. It’s very sad to hear Cooper cry,” said Dyer.

“Mobile technologies are changing the way we see health, and more importantly, the delivery of health care,” said Fabio Gratton, chief alchemist at Palio+Ignite. “We believe that gamification in mHealth can have a significant impact on the lives of patients by engaging and supporting them in their goal for better health – and that’s what Dr. Dyer’s app is all about.”

Gratton, a speaker at the inaugural Social Health Un-Conference that started it all 2 years ago, first met Dyer at SXSW 2011 while interviewing her on behalf of Gwee’s PharmFresh.TV on the role of mobile health applications in patient care. “She totally got it, before anyone was really talking about mHealth. When I saw she was on MedStartr trying to raise funds to conduct a clinical trial for her latest app, I knew we had to help out and be a part of it.”

EndoGoal is not only an interactive diabetes management tool, but it is also a resource for diabetes education. The medical tab of the app holds answers to all sorts of diabetes questions, keeping patients involved and up-to-date on diabetes health news. Diabetes blogs and articles can be accessed and shared within the diabetes community when using EndoGoal.

For the clinical trials, insulin-dependent diabetics will be recruited and asked to use the app for 3 months. A survey will be distributed at the beginning to record baseline results and an additional survey will be used to measure behavioral changes after the 3-month timespan. Dyer anticipates finding significant results in the clinical trials, proving that EndoGoal can help those with diabetes manage their disease and live healthier lives. Clinical trials will begin this spring, allowing the study to be peer reviewed for health publications.

For more information on the Social Health Startup Bootcamp, visit: Follow #SXSHbooty on Twitter.

Palio+Ignite is an advertising agency revolutionizing healthcare marketing by leveraging the art and science of today with the technology and imagination of tomorrow. For more information, visit


Infographic illustrates engagement of audiences

Saratoga Springs, NY, February 26, 2013 ­­– Palio+Ignite, an inVentiv Health agency, partnered with healthcare market research and advisory firm Manhattan Research, online patient community network Inspire, and patient advocacy organization Neurofibromatosis Network to help visualize key social media trends in neurofibromatosis.

Neurofibromatosis (NF) is a genetic disorder of the nervous system, which causes tumors to grow on the nerves. It affects 1 in every 2500 births per year, and affects both sexes equally, with no particular racial, geographic, or ethnic targets. “Unfortunately, there is no cure. Treatment is a means to control symptoms that can be debilitating for some,” said Kim Bischoff, Executive Director of the Neurofibromatosis Network. 

Manhattan Research and Inspire allied with the Neurofibromatosis Network to explore the role of social media in the lives of NF patients and caregivers. The study was conducted online among 161 patients and 57 caregivers from the Inspire/Neurofibromatosis Network’s Support Community.

Research findings on the Neurofibromatosis Social Media Trends infographic show that those who are highly engaged in social media, more than half of patients and 3 in 5 caregivers, use social media at least once a week. Also indicated is that caregivers are more immersed with information and support related to NF online communities than their patients.

The infographic, created by Palio+Ignite’s Labs team, details how baby boomers engage with online communities for condition management more so than those of Generation X-Y. Finally, the study indicates that patients with moderate-to-severe NF participate more often in online communities than those with mild NF, indicating the importance the online community plays in providing an environment to discuss the disease with others who have it. Click here to see the infographic:

According to Bischoff, with the sixth global Rare Disease Day on February 28, “The time is ripe to leverage social media to increase outreach and education efforts to bring awareness about NF and correctly inform the public so those affected can seek help, gain support, and not feel isolated or alone.” 

Fabio Gratton, Chief Alchemist at Palio+Ignite, has been a key driver in both the agency’s data visualization initiative as well as the partnership with Manhattan Research. “I can’t think of a better place to apply the power of infographics than using it to understand how people in rare disease communities, such as neurofibromatosis, are interacting. Because it’s already challenging to find information and support, it’s imperative that all those involved in helping these communities understand their needs; this type of data visualization can help do that.”

This is the sixth infographic Palio+Ignite has created for Manhattan Research since the 2 organizations first agreed to partner last fall. Manhattan Research President Meredith Ressi also noted, “Once again, Palio+Ignite showcases their amazing skills in the area of visual storytelling.”

Palio+Ignite is an advertising agency revolutionizing healthcare marketing by leveraging the art and science of today with the technology and imagination of tomorrow. For more information, visit


About Palio+Ignite

Palio+Ignite is a full-service agency that enables healthcare and pharmaceutical companies to reach and engage audiences through the power of communications. The agency is a creative force within the marketplace and brings differentiating strengths to the table: medical strategy, REMS, managed markets, market research, social marketing, health gaming and animation, brand strategy, insight and analytics, global outreach, digital communications and interactive development, mobile health, and emerging technologies. We have the ability to provide clients with a heightened level of synergy and engagement through ideas and innovation. Palio+Ignite is part of inVentiv Health Communications (iHC), the inVentiv Health division dedicated to delivering exceptional, global, multichannel communications to organizations focused on health and wellness.

About Inspire

Princeton, NK-based Inspire creates safe, moderated online communities, organized by medical condition, for patients to share information and to support each other. Inspire builds and manages these communities in partnership with more than 80 national patient advocacy and support organizations. Among the organizations are the National Osteoporosis Foundation, the Ovarian Cancer National Alliance, and the Asthma and Allergy Foundation of America. For more information, go to or call us at 1.800.945.0381.

About Manhattan Research

Manhattan Research, a Decision Resources Group company, conducts annual research studies covering digital health trends among healthcare professionals and consumers in the Americas, Europe, and Asia-Pacific. Broad research can be segmented by target specialist and therapeutic audiences. For more information, please contact, call 1.888.680.0800, ext 2, or visit

About Neurofibromatosis Network

Neurofibromatosis Network is the leading national organization advocating for federal funding for NF research and the development of local NF organizations. Neurofibromatosis Network was founded in 1988 by several strong local NF organizations wishing to establish a national NF organization that allowed for autonomy within the individual organizations as well as collaboration on actives that were national in nature.